| Systematic (IUPAC) name | |
|---|---|
| ethyl 1-(2-morpholin-4-ylethyl)-4-phenyl-piperidine-4-carboxylate | |
| Clinical data | |
| Pregnancy cat. | ? |
| Legal status | CD (UK) Schedule I (US) international schedule I |
| Identifiers | |
| CAS number | 469-81-8 |
| ATC code | None |
| PubChem | CID 61121 |
| ChemSpider | 55069 |
| UNII | 1854GKB41Y |
| Chemical data | |
| Formula | C20H30N2O3 |
| Mol. mass | 346.46 g/mol |
| SMILES | eMolecules & PubChem |
|
|
| |
|
Morpheridine (Morpholinoethylnorpethidine)[1] is a 4-phenylpiperidine derivative that is related to the opioid analgesic drug pethidine (meperidine). It is a strong analgesic with around 4 times the potency of pethidine,[2] and unlike pethidine, does not cause convulsions, although it produces the standard opioid side effects such as sedation and respiratory depression.[3]
Morpheridine is not currently used in medicine and is a Schedule I drug which is controlled under UN drug conventions.[4]
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||
| This analgesic-related article is a stub. You can help Wikipedia by expanding it. |
This entry is from Wikipedia, the leading user-contributed encyclopedia. It may not have been reviewed by professional editors (see full disclaimer)